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Visceral leishmaniasis is characterized by fever, cachexia, hepatosplenomegaly, pancytopenia, and hypergammaglobulinemia.
Cough may be a presenting symptom as well. However, pulmonary involvement is considered rare and mainly described in
immunocompromised patients. We describe a case of an immunocompetent adult whose clinical presentation was dominated by
coughandhemoptysis.Bronchoscopyrevealedadiscreet polypoidmucosalendobronchiallesionwhosebiopsyyielded Leishmania
amastigotes within histiocytes. Transbronchial needle biopsy of a right paratracheal lymph node was also positive. Leishmania
amastigoteswere alsofound onbone marrow and liver biopsies. Treatment with IV Amphotericin B was successful. In conclusion,
cough should not be overlooked as a presenting symptom of visceral leishmaniasisand may be a sign of pulmonary involvement.
1.Introduction
Leishmaniasis is a parasitic disease with a wide range of
clinicalmanifestations dependingontheinteractionbetween
diﬀerent Leishmania species and immune host responses.
Most infections being asymptomatic, three main clinical
syndromes are recognized, namely, visceral, cutaneous, and
mucocutaneous.
Visceral leishmaniasis (VL) is the most severe form with
an annual incidence of about 500 000 cases and a respective
mortality of 80 000 [1].
With 90% of cases occurring in ﬁve countries, namely
Bangladesh, NE India, Nepal, Sudan, and NE Brazil, the
disease could be mistakenly considered rare in Europe [2].
Nevertheless, the Mediterranean littoral constitutes an
endemic area, with Leishmania infantum as the causative
agent. Factors such as immigration and global warming may
further contribute to disease propagation [3, 4].
Moreover, the increase in the number of immunocom-
promised patients has resulted in an increased incidence of
VL and novel clinical presentations [5].
VL is characterized by fever, cachexia, hepatospleno-
megaly (predominantly splenomegaly), pancytopenia, and
hypergammaglobulinemia.
Lung involvement is considered rare, especially in
immunocompetent patients.
We report a case of VL in an immunocompetent
man with clinical and bronchoscopically conﬁrmed endo-
bronchialandmediastinalinvolvementandbrieﬂyreviewthe
pertinent literature.
2.Case Presentation
A 40-year-old man of Albanian descent, living in Athens the
last 20 years, was admitted on February 2008. His symptoms
began one year prior to admission with dry cough and
gradual weight loss of a total of 30kg. Night sweats and
scant hemoptysis appeared the last month. Alimited workup
6 months ago had revealed the presence of chronic active
hepatitis B.
The patient was working in a restaurant, was a non-
s m o k e r ,a n dh a dn oo t h e rr e m a r k a b l em e d i c a lh i s t o r y .2 Case Reports in Medicine
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Figure 1: Endoscopic view from the lower part of the bronchus
intermedius. The mucosa appears inﬂamed and slightly nodular at
the level of the middle lobe bronchus,on the anteromedial wall.On
the middle lobe carina, there is a discreet polypoid lesion. RML:
right middle lobe bronchus. RLL: right lower lobe bronchus.
Clinicalexamination revealedcachexia,hepatosplenomegaly,
and small, discrete, and nontender axillary and cervical
lymph nodes. There were no clinical signs of liver failure
or portal hypertension such as jaundice, palmar erythema,
spider nevi, encephalopathy, or ascites.
Laboratory tests showed pancytopenia, elevated hepatic
aminotransferases (3-4 timestheupperlimit) and polyclonal
hypergammaglobulinemia. Erythrocyte Sedimentation Rate
was 100mm/h. Serum albumin, bilirubin and prothrombin
time, were within normal limits. HIV was tested negative
by ELISA twice by three months apart. Antibodies against
Hepatitis C virus were negative as well. An abdominal
ultrasound revealed increased dimensions of the liver and
spleen and the presence of enlarged lymph nodes at the
hepatic hilum. Diameter and ﬂow through the portal vein
were normal, and no ascites was detected. A Computerized
Tomography scan of the chest revealed limited adenopathy;
a2× 1cm mass at the right hilum, and a 1.2cm right lower
paratracheal lymph node with hypodense centre.
On bronchoscopy, epistaxis and pharyngeal inﬂamma-
tion consistent with candidiasis were noticed. There was
mild diﬀuse redness throughout the tracheobronchial tree.
Inﬂammation was more prominent on the medial aspect
of the bronchus intermedius extending into the middle
lobe bronchus. Interestingly, a discreet mucosal polypoid
lesion was observed on the middle lobe carina (Figure 1).
Bronchial biopsies taken from this lesion revealed epithe-
lial hyperplasia and several Leishmania amastigotes within
histiocytes (Figures 2(a) and 2(b)). Transbronchial needle
biopsies (TBNB) targeted at the right lower paratracheal
lymph node also revealed histiocytes containing abundant
Leishmania amastigotes (Figure 3).
A bone marrow biopsy was also positive for Leishmania
amastigotes, as was a liver biopsy. In the latter, there was
considerablehepatic inﬂammation, attributed to bothLeish-
mania and HBV infection, along with minimal ﬁbrosis
but not cirrhosis. Fluorescent antibodies against Leishmania
were positive in high titers of ≥1/640.
(a)
(b)
Figure 2: (a) Bronchial biopsy showing epithelial hyperplasia and
few Leishmania amastigotes within subepithelial histiocytes (white
arrowhead). (Hematoxylin-Eosin ×200). (b) A higher magniﬁca-
tion view of the positive area. Several collections of Leishmania
amastigotes are indicated by black arrowheads (Giemsa ×1000).
Figure 3: Transbronchial needle biopsy of a mediastinal lymph
node showing histiocytes containing abundant Leishmania
amastigotes (H-E × 1000). Insert shows a close-up view of an
amastigote. Its ovoid shape, eccentric nucleus, and kinetoplast are
discerned.
The patient was treated with IV liposomal Amphotericin
Bw i t hp r o m p tc l i n i c a la n dl a b o r a t o r yi m p r o v e m e n t .S i x
months later, white blood cell count and diﬀerential, lym-
phocyte subpopulations, and immunoglobulin levels were
within normal limits. Due to the persistence of increased
hepatic aminotransferases (1.5 times the upper limit) the
patient began treatment with telbivudine. On the ﬁrst and
second year follow up, the patient remained in excellent
clinical condition and had normal laboratory values.Case Reports in Medicine 3
3.Discussion
We describe a case of visceral leishmaniasis in an immuno-
competent adult who presented with cough and hemop-
tysis along with the typical clinical features of the dis-
ease. Involvement of bronchial mucosa resulted in mild
diﬀuse inﬂammation, but most importantly in a visible
endobronchial lesion whose biopsy yielded amastigotes of
Leishmania withinhistiocytes.Histologywasalsopositivefor
a lower paratracheal node accessed through transbronchial
needle biopsy.
Clinical lung involvement in VL is considered rare. How-
ever, a persistent dry cough is an overlooked, yet quite com-
monfeatureofVL,observedinupto83%ofaﬀectedpatients
[6–8]. It may be a presenting symptom and may accompany
the illness until eﬀective treatment is administered. While
cough can originate outside the lungs, pulmonary involve-
ment in VL has been indeed demonstrated.
Interstitial pneumonitis with a mainly mononuclear cell
inﬁltrate and foci of ﬁbrosis has been shown in experi-
mentally infected mice and naturally infected dogs [9, 10].
Furthermore, following earlier observations in humans, an
autopsy study in Brazil demonstrated interstitial pneumoni-
tis and Leishmania antigenic material in 10 out of 13 cases
of VL. The parasite itself was identiﬁed in 3 cases. Lesions
within the bronchi were not detected. Clinical features were
unfortunately not recorded [11].
A Th2 polarized immune response with deﬁcient IFN-
gamma production has been recently demonstrated within
the lung interstitium in cases of VL with pulmonary involve-
ment [12]. This inﬂammatory pattern—which is consistent
with the immune response in other aﬀected organs—could
beresponsiblefortheincreasedsusceptibilityofpatientswith
VL to respiratory infections.
Bronchial involvement in VL has been reported in an
immunocompetent patient from Sudan; Leishmania dono-
vani was identiﬁed using PCR in bronchoalveolar lavage and
bronchial biopsies. This man had also involvement of the
nasal and oropharyngeal mucosa as well as massive medi-
astinal lymphadenopathy and generalized inﬂammation of
the bronchial tree. No discrete lesion was identiﬁed on the
bronchial mucosa, and amastigotes were not seen on stains.
Histopathology was characterized by granulomatous inﬂam-
mation. Moreover, the authors concluded that this patient
had an immunological proﬁle more akin to mucocutaneous
or post kala azar dermal leishmaniasis than to VL [13].
Another case of endobronchial involvement in VL has
been described in a man with signiﬁcant immunosuppres-
sion and HIV-related infections. Bronchial lesions were
reportedtomacroscopicallyresembleKaposisarcoma.Leish-
maniaamastigoteswerefoundwithinsubmucosalhistiocytes
as in our case but without concomitant epithelial reaction.
Bronchoscopic images were not provided [14].
Predictably, pulmonary involvement in VL is more often
reported in immunocompromised patients, particularly
those infected by HIV. In fact, Leishmania has emerged as
an important opportunistic infection in the HIV-positive
population; in southern Europe, 25% to 70% of adult VL
casesinvolveHIV-positivepatients[2].Itisworthnotingthat
Leishmania infection may by itself foster HIV infection by
promoting viral replication [15].
VL in the presence of HIV may present atypical clinical
manifestations and aﬀect unusual sites [5]. Leishmania was
ﬁrst described to aﬀect the lungs of a patient with AIDS in
1991 [16]. Subsequently, it has been described as a cause of
pulmonaryinﬁltrates[17],asolitarypulmonarynodule[18],
diﬀuse pulmonary and pleural disease [19, 20], lung masses
[21], and bronchioloalveolar adenoma [22].
Apart from HIV infection, VL is diagnosed with
increased frequency among other immunocompromised
groups such as solid organ transplant recipients, including
of lung transplants [23].
Our patient’s history and clinical course after treating
VL did not suggest any concrete immune defect. Hepatitis
B virus is not known to directly aﬀect the immune system;
still, cirrhosis and liver failure may be associated with some
degree of immune suppression, mainly, in advanced stages.
However, most of the hepatic dysfunction in our patient
should be attributed to Leishmania infection as shown
by the clinical and laboratory recovery under treatment.
Hepatic failure was never present and liver histopathology
ﬁndings were not suﬃcient to document cirrhosis. In fact,
hepatic inﬂammation and ﬁbrosis, occasionally leading to
cirrhosis, have been recognized as complications of the
hepatic involvement in VL [24]. Nevertheless, we cannot
deﬁnitely exclude a possible contribution of subtle liver
failure caused by chronic hepatitis B on the acquisition and
expression of Leishmania infection in our patient. On the
other hand, it is also possible that immune dysregulation
caused by Leishmania infection [25] might have promoted
and aggravated HBV infection [26].
Clinical and laboratory features of VL overlap with those
of chronic hepatitis B with cirrhosis [27]. Indeed, in our
patient, enlargement of the liver and spleen together with
laboratory abnormalities was initially attributed to chronic
HBV infection. The presence of cough and particularly
hemoptysis further confounded the diagnosis. Bleeding
from the tracheobronchial tree was not observed during
bronchoscopy, and consequently, an upper airway origin
could be equally possible. In light of the ﬁnal diagnosis,
epistaxis and pharyngeal inﬂammation could represent
Leishmania infection of the upper airway mucosa; no
biopsies were taken to verify this hypothesis. It is noteworthy
that the bronchoscopic appearance of the middle lobe
carina lesion was similar to lesions described on the larynx
[28, 29].
Mucocutaneous disease is generally reported in Latin
America and is caused by Leishmania braziliensis [1]. How-
ever, mucosal involvement of the oral cavity—including
tongue and tonsils—the nose, the pharynx, and the larynx, is
aninfrequentbutwell-described complicationof Leishmania
infantum infection. It is not conﬁned to immunocompro-
misedpatientsandmayoccureitherisolatedorinthecontext
of visceral disease. Lesions may appear as nodular swelling or
tumor like and less often as ulcerative. A chronic inﬂamma-
tory inﬁltrate is observed on histopathology. Granulomatous
inﬂammation is oftenbutnotuniversally demonstrated [29].4 Case Reports in Medicine
Histopathology of the endobronchial lesion was char-
acterized by the absence of signiﬁcant submucosal inﬂam-
mation despite the presence of infected histiocytes, and
by the hyperplasia of the respiratory epithelium. Cases
of documented endobronchial leishmaniasis are rare, and
therefore we cannot draw meaningful conclusions from
these observations. Nevertheless, these ﬁndings are not
unprecedented since both insigniﬁcant inﬂammation [14]
and hyperplastic epithelial cells [21] have been reported in
respective cases. More importantly, a signiﬁcant hyperplasia
of the respiratory epithelium of terminal and respiratory
bronchioles has been observed in dogs naturally infected
with Leishmania chagasi [10].
Despite the limited number of reported cases, the diver-
sity ofclinical and histopathologic expressions ofpulmonary
involvement in VL is remarkable. The interactions between
diﬀerentLeishmania speciesandimmunehostresponsesthat
account for these diﬀerences are not yet elucidated.
In this context, it would have been interesting to char-
acterize the species of the parasite that aﬀected our patient.
U n f o r t u n a t e l y ,n e i t h e rc u l t u r en o rP C Rf o rL e i s h m a n i a
species are available in our hospital. In Greece, VL is caused
by Leishmania infantum, zymodeme MON-1. Phlebotomine
sand ﬂies are responsible for transmission, and dogs are
the only known reservoir hosts. Rare cases of cutaneous
disease are caused by the same parasite. Seroprevalence in
northern Greece has been recently assessed between 2–2.8%
[30]which isclosetothatofothersouthEuropean countries.
AnnualincidenceinGreeceisestimatedbetween0.19and1.0
cases per 100 000 inhabitants [6, 30, 31].
4.Conclusion
We describe a unique case of a discrete endobronchial
lesion related to Leishmania infection. It is possible that
the application of diagnostic methods not available in
the past, such as ﬁberoptic bronchoscopy and TBNB, will
enrich our knowledge on the pulmonary involvement in
VL. Meanwhile, Leishmania infection may increase itspreva-
lence, propagate geographically, and present novel clinical
features in relation to immigration, climate change and
immunosuppression.
Cough should not be overlooked as a presenting symp-
tomofvisceralleishmaniasis andmaybeasign ofpulmonary
involvement.
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